TABLE 1.
Variable | All participants | Relative risk CVD | p | |
---|---|---|---|---|
High risk | Others | |||
N (%) | n (%) | n (%) | ||
Participants | 301 (100) | 61 (20.3) | 240 (79.7) | |
Sex | ||||
Male | 169 (56.1) | 27 (44.3) | 142 (59.2) | .051 |
Female | 132 (43.9) | 34 (55.7) | 98 (40.8) | |
Age groups, years | ||||
≤25 | 79 (26.2) | 7 (11.5) | 72 (30.0) | <.001 |
25–40 | 141 (46.8) | 25 (40.9) | 116 (48.3) | |
≥40 | 81 (26.9) | 29 (47.5) | 52 (21.7) | |
Education groups, years | ||||
≤12 | 264 (87.7) | 56 (91.8) | 208 (86.7) | .383 |
>12 | 37 (12.3) | 5 (8.2) | 32 (13.3) | |
Schedule | ||||
Morning | 153 (50.8) | 32 (52.5) | 121 (50.4) | .179 |
Evening | 120 (39.9) | 20 (32.8) | 100 (41.7) | |
Night | 28 (9.3) | 9 (14.8) | 19 (7.9) | |
SDur workdays, hr | ||||
>6 | 181 (60.1) | 27 (44.3) | 154 (64.2) | .007 |
≤6 | 120 (39.9) | 34 (55.7) | 86 (35.8) | |
Sleep quality | ||||
≥Good | 205 (68.1) | 39 (63.9) | 166 (69.2) | .529 |
≤Poor | 96 (31.9) | 22 (36.1) | 74 (30.8) | |
Social jet lag | ||||
≤2 | 179 (59.4) | 31 (50.8) | 148 (61.7) | .065 |
2−4 | 98 (32.6) | 21 (34.4) | 77 (32.1) | |
≥4 | 24 (8.0) | 9 (14.8) | 15 (6.2) | |
Physical exercise, min/week | ||||
≥150 | 56 (20.4) | 3 (9.8) | 53 (31.7) | .002 |
<150 | 219 (79.6) | 55 (90.2) | 164 (68.3) | |
Alcohol, drink/day | ||||
≤1 | 272 (90.4) | 54 (88.5) | 218 (90.8) | .762 |
>1 | 29 (9.6) | 7 (11.5) | 22 (9.2) | |
Caffeine, drinks/day | ||||
≤3 | 212 (70.4) | 30 (49.1) | 182 (75.8) | <.001 |
>3 | 89 (29.6) | 31 (50.8 | 58 (24.2) | |
BMI, kg/m2 | ||||
<25 | 187 (62.1) | 39 (63.9) | 148 (61.7) | .859 |
≥25 | 114 (37.9) | 22 (36.1) | 92 (38.3) | |
Smoking | ||||
No | 149 (49.5) | 1 (1.6) | 148 (61.7) | <.001 |
Yes | 152 (50.5) | 60 (98.4) | 92 (38.3) | |
Hypertension, blood pressure, mmHg | ||||
<140 and 90 | 269 (89.4) | 221 (92.1) | 48 (78.7) | .005 |
≥140 or 90 | 32 (10.6) | 19 (7.9) | 13 (21.3) | |
Hypercholesteraemia, total cholesterol, mg/dl | ||||
<190 | 154 (51.2) | 8 (13.1) | 146 (60.8) | <.001 |
≥190 | 147 (48.8) | 53 (86.9) | 94 (39.2) |
Abbreviations: BMI, body mass index; CVD, cardiovascular disease; SDur, sleep duration.
Relative frequencies in CVD risk categories refer to the prevalence within “high‐risk CVD” and “others” groups. Data is presented as absolute (n) and relative (%) frequencies. p value for Chi‐square test (with continuity correction when 2 × 2). Statistically significant associations are presented in bold (p < .05). High‐risk CVD: Systematic COronary Risk Evaluation (SCORE) ≥3; others: SCORE ≤2.